The European Commission today issued a release concerning value added tax (VAT) relief measures allowing EU Member States to provide a VAT exemption for EU hospitals, medical practitioners, and individuals when acquiring coronavirus (COVID-19) vaccines and testing kits.
As noted in an EC release, the new rules were adopted unanimously by all EU Member States.
The measures will allow EU countries to put in place a temporary VAT exemption for vaccines and testing kits being sold to hospitals, doctors, and individuals. Currently, EU Member States can apply reduced VAT rates on sales of vaccines but cannot apply a zero rate, while testing kits cannot benefit from reduced rates. Under the amended Directive, EU Member States will be able to apply either reduced or zero rates to both vaccines and testing kits.
The new rules will apply from the day after their publication in the Official Journal of the European Union and will remain in place until the end of 2022, or until an agreement is reached on the EC's pending proposal for new rules on VAT rates, whichever is earlier.
The KPMG logo and name are trademarks of KPMG International. KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever. The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.